12 May 2015

Broadway House, Tothill Street, London

The meeting will start promptly at 10:10 and is expected to finish at approximately 17:00

Please note that this agenda is subject to change prior to the meeting.

Final Agenda

  1. Welcome and introductions – Part 1 only (open session)
  2. Code of Conduct for members of the public attending the meeting – Part 1 only (open session)
  3. Declarations of Interest – Part 1 only (open session)
  4. Objectives of the day – Part 1 only (open session)
  5. Headaches updatePart 1 only (open session)
    • Review of the clinical evidence
      • Review question: "In people with chronic or episodic migraine (with or without aura), what is the clinical evidence and cost-effectiveness of prophylactic pharmacological treatment with":
        1. ACE (angiotensin converting enzyme) inhibitors and angiotensin II receptor antagonists
        2. Antidepressants (SNRIs, SSRIs, tricyclics)
        3. Centrally acting alpha-adrenergic-receptor agonists
        4. Beta blockers
        5. Calcium channel blockers
        6. Antiepileptics
        7. Other serotonergic modulators
        8. NMDA receptor antagonists
  6. Reflections of the day and AOB – Part 2 only (closed session)

Date, time and venue of next meeting: 22 & 23 June 2015 10am, NICE offices, City Tower, Piccadilly Plaza, Manchester, M1 4BT

Please note all timings are approximate.

To print this agenda, please right click and select ‘Print’ from the menu

You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.

The closing date for registration is Thursday 30 April 2015. Please note that it may not be possible to accept late registration requests.

Should you have any queries regarding attending this meeting, please contact the Meetings in Public Coordinator Jon Littler

Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email nice@nice.org.uk   

Further information about conducting research is also available in our Common Questions and Answers about meetings in public document.


Registration period: 13 to 30 April 2015
Registration is closed.